Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 174,813 |
|
|||||
| News | - | ||||||
| Day High | 3.88 | Low High |
|||||
| Day Low | 2.54 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Salarius Pharmaceuticals Inc | SLRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.56 | -16.09% | 2.92 | 19:57:43 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.57 | 2.54 | 3.88 | 2.9882 | 3.48 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,267 | 174,813 | $ 3.38 | $ 590,399 | - | 0.3868 - 3.88 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:17:23 | 49 | $ 2.9201 | USD |
Salarius Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 11.78M | 3.94M | - | 0 | -12.54M | -3.18 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Salarius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.4258 | 3.88 | 0.3868 | 1.37 | 117,738 | 2.49 | 585.77% |
| 1 Month | 0.4897 | 3.88 | 0.3868 | 0.9935831 | 52,176 | 2.43 | 496.28% |
| 3 Months | 0.49 | 3.88 | 0.3868 | 0.6585525 | 51,367 | 2.43 | 495.92% |
| 6 Months | 0.6599 | 3.88 | 0.3868 | 0.5895055 | 74,926 | 2.26 | 342.49% |
| 1 Year | 1.54 | 3.88 | 0.3868 | 0.6927645 | 63,633 | 1.38 | 89.61% |
| 3 Years | 26.00 | 30.00 | 0.3868 | 13.18 | 399,507 | -23.08 | -88.77% |
| 5 Years | 288.75 | 370.385 | 0.3868 | 28.58 | 557,177 | -285.83 | -98.99% |
Salarius Pharmaceuticals Description
| Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. |
